Here's how STEMCELLRES.BIOMEDCENTRAL.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

STEMCELLRES . BIOMEDCENTRAL . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Stemcellres.biomedcentral.com Make Money
  6. How Much Does Stemcellres.biomedcentral.com Make
  7. Keywords
  8. Topics
  9. Questions
  10. Schema
  11. Social Networks
  12. External Links
  13. Analytics And Tracking
  14. Libraries
  15. CDN Services

We are analyzing https://stemcellres.biomedcentral.com/articles/10.1186/s13287-023-03334-3.

Title:
Side population cells derived from hUCMSCs and hPMSCs could inhibit the malignant behaviors of Tn+ colorectal cancer cells from modifying their O-glycosylation status | Stem Cell Research & Therapy | Full Text
Description:
Background Cosmc (C1GalT1C1) mutation could cause aberrant O-glycosylation and result in expression of Tn antigen on the surface of tumor cells (Tn+ cells), which is associated with the metastasis and prognosis of cancer progression. Mesenchymal stem cells (MSCs) could participate in immunoregulation, tissue damage repair, and tumor inhibition and be seen as an ideal candidate for tumor therapy due to their inherent capacity to migrate to tumor sites. However, their therapeutic effectiveness in different tumors is inconsistent and still controversial. Of note, emerging data reveal that side population (SP) cells have a stronger multilineage developmental potential than main population cells and can function as stem/progenitor cells. The effect of SP cells derived from MSCs on the biological behaviors and the O-glycosylation status of tumor cells remains unclear. Methods SP cells were isolated from human umbilical cord MSCs (hUCMSCs) and human placenta MSCs (hPMSCs). Tn+ cells (LS174T-Tn+ and HT-29-Tn+ cells) and matching Tnāˆ’ cells (LS174T-Tnāˆ’ and HT-29-Tnāˆ’ cells) were isolated from human colorectal cancer cell (CRC) lines LS174T and HT-29 by immune magnetic beads. The proliferation, migration, apoptosis, Tn antigen expression, and O-glycome in Tn+ and Tnāˆ’ CRC cells before and after co-cultured with SP-MSCs were detected using real-time cell Analysis (RTCA), flow cytometry (FCM), and cellular O-glycome reporter/amplification (CORA), respectively. Cosmc protein and O-glycosyltransferase (T-synthase and C3GnT) activity in CRC cells were, respectively, assessed using western blotting and fluorescence method. Results Both SP cells derived from hUCMSCs and hPMSCs could inhibit proliferation and migration, promote apoptosis of CRC cells, significantly reduce Tn antigen expression on Tn+ CRC cells, generate new core 1-, 2-, and 3-derived O-glycans, increase T-synthase and C3GnT activity, and elevate the levels of Cosmc and T-synthase protein. Conclusion SP-hUCMSCs and SP-hPMSCs could inhibit proliferation and migration and promote apoptosis of Tn+ CRC cells via increasing O-glycosyltransferase activity to modify O-glycosylation status, which further adds a new dimension to the treatment of CRC.
Website Age:
25 years and 10 months (reg. 1999-08-06).

Matching Content Categories {šŸ“š}

  • Science
  • Education
  • Health & Fitness

Content Management System {šŸ“}

What CMS is stemcellres.biomedcentral.com built with?

Custom-built

No common CMS systems were detected on Stemcellres.biomedcentral.com, and no known web development framework was identified.

Traffic Estimate {šŸ“ˆ}

What is the average monthly size of stemcellres.biomedcentral.com audience?

šŸš€šŸŒ  Tremendous Traffic: 10M - 20M visitors per month


Based on our best estimate, this website will receive around 12,900,687 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Stemcellres.biomedcentral.com Make Money? {šŸ’ø}


Display Ads {šŸŽÆ}


The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.

Ads are managed by yourbow.com. Particular relationships are as follows:

Direct Advertisers (3)
yourbow.com, google.com, doceree.com

How Much Does Stemcellres.biomedcentral.com Make? {šŸ’°}


Display Ads {šŸŽÆ}

$162,600 per month
Estimations show Stemcellres.biomedcentral.com's display ad online revenue falls between $108,408 and $298,121 per month.

Keywords {šŸ”}

cells, pubmed, crc, cell, article, lsttn, cancer, httn, google, scholar, cocultured, antigen, mscs, tumor, oglycans, stem, cas, spmscs, tsynthase, core, sphpmscs, fig, sphucmscs, derived, mesenchymal, cosmc, migration, apoptosis, activity, central, expression, human, proliferation, huvecs, hpmscs, cgnt, hucmscs, oglycosylation, protein, colorectal, data, tissue, china, colon, inhibit, results, differentiation, tissues, usa, wang,

Topics {āœ’ļø}

complex structure galβ1-3galnac-1-o-ser/thr ser/thr formed galnac-1-o-ser/thr mtor/hif-1alpha/vegf signaling axis dkk-1/wnt/beta-catenin signaling pathway complex disease–mucin-type o-glycans cellular o-glycome reporter/amplification gal β1-3 galnac-ser/thr apc-labeled anti-ssea-3 antibody supplementary figures real-time impedance-based assays springer nature multilineage-differentiating stress enduring induce epithelial–mesenchymal transition glcnac-galnac-ser/thr anti-mouse igm microbeads aberrant o-glycosylation contributes msc-derived extracellular vesicles promote ligand-stimulated clustering nf-kappab signaling pathway galnt14-mediated dr5 glycosylation tumor-bearing nude mice proapoptotic ligand apo2l/trail healthy-term pregnant women core 1-derived o-lycans modify o-glycosylation status core 2-derived o-glycan core 3-derived o-glycan core 1-derived o-glycan modify abnormal o-glycosylation core 1-derived o-glycans core 3-derived o-glycans core 2-derived o-glycans bone marrow-derived mscs centrifugation bn-o-glycans apc-labeled anti-tn correct abnormal o-glycosylation compound bn-α-galnac anti-tumour immune response o-linked glycan branching t-synthase promote ls174t-tnāˆ’ real-time cell analysis additional information publisher' bmc cancer rabbit anti-t-synthase truncated o-glycans expressed secondary antibody conjugated human colorectal cancer 10% sds-page aberrant o-glycosylation data materials

Questions {ā“}

  • Are mesenchymal cells indeed pluripotent stem cells or just stromal cells?
  • Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response?

Schema {šŸ—ŗļø}

WebPage:
      mainEntity:
         headline:Side population cells derived from hUCMSCs and hPMSCs could inhibit the malignant behaviors of Tn+ colorectal cancer cells from modifying their O-glycosylation status
         description:Cosmc (C1GalT1C1) mutation could cause aberrant O-glycosylation and result in expression of Tn antigen on the surface of tumor cells (Tn+ cells), which is associated with the metastasis and prognosis of cancer progression. Mesenchymal stem cells (MSCs) could participate in immunoregulation, tissue damage repair, and tumor inhibition and be seen as an ideal candidate for tumor therapy due to their inherent capacity to migrate to tumor sites. However, their therapeutic effectiveness in different tumors is inconsistent and still controversial. Of note, emerging data reveal that side population (SP) cells have a stronger multilineage developmental potential than main population cells and can function as stem/progenitor cells. The effect of SP cells derived from MSCs on the biological behaviors and the O-glycosylation status of tumor cells remains unclear. SP cells were isolated from human umbilical cord MSCs (hUCMSCs) and human placenta MSCs (hPMSCs). Tn+ cells (LS174T-Tn+ and HT-29-Tn+ cells) and matching Tnāˆ’ cells (LS174T-Tnāˆ’ and HT-29-Tnāˆ’ cells) were isolated from human colorectal cancer cell (CRC) lines LS174T and HT-29 by immune magnetic beads. The proliferation, migration, apoptosis, Tn antigen expression, and O-glycome in Tn+ and Tnāˆ’ CRC cells before and after co-cultured with SP-MSCs were detected using real-time cell Analysis (RTCA), flow cytometry (FCM), and cellular O-glycome reporter/amplification (CORA), respectively. Cosmc protein and O-glycosyltransferase (T-synthase and C3GnT) activity in CRC cells were, respectively, assessed using western blotting and fluorescence method. Both SP cells derived from hUCMSCs and hPMSCs could inhibit proliferation and migration, promote apoptosis of CRC cells, significantly reduce Tn antigen expression on Tn+ CRC cells, generate new core 1-, 2-, and 3-derived O-glycans,Ā increase T-synthase and C3GnT activity, and elevate the levels of Cosmc and T-synthase protein. SP-hUCMSCs and SP-hPMSCs could inhibit proliferation and migration and promote apoptosis of Tn+ CRC cells via increasing O-glycosyltransferase activity to modify O-glycosylation status, which further adds a new dimension to the treatment of CRC.
         datePublished:2023-05-26T00:00:00Z
         dateModified:2023-05-26T00:00:00Z
         pageStart:1
         pageEnd:19
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s13287-023-03334-3
         keywords:
            Colorectal cancer cells
            SP-hUCMSCs
            SP-hPMSCs
             O-glycosylation
            Cosmc
            Stem Cells
            Cell Biology
            Regenerative Medicine/Tissue Engineering
            Biomedical Engineering and Bioengineering
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13287-023-03334-3/MediaObjects/13287_2023_3334_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13287-023-03334-3/MediaObjects/13287_2023_3334_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13287-023-03334-3/MediaObjects/13287_2023_3334_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13287-023-03334-3/MediaObjects/13287_2023_3334_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13287-023-03334-3/MediaObjects/13287_2023_3334_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13287-023-03334-3/MediaObjects/13287_2023_3334_Fig6_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13287-023-03334-3/MediaObjects/13287_2023_3334_Fig7_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13287-023-03334-3/MediaObjects/13287_2023_3334_Fig8_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13287-023-03334-3/MediaObjects/13287_2023_3334_Fig9_HTML.png
         isPartOf:
            name:Stem Cell Research & Therapy
            issn:
               1757-6512
            volumeNumber:14
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Wen Hu
               affiliation:
                     name:Binzhou Medical University
                     address:
                        name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ruisong Ding
               affiliation:
                     name:Binzhou Medical University
                     address:
                        name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mengyang Wang
               affiliation:
                     name:Binzhou Medical University
                     address:
                        name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Panpan Huang
               affiliation:
                     name:Binzhou Medical University
                     address:
                        name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xia Wei
               affiliation:
                     name:Binzhou Medical University
                     address:
                        name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xingyou Hu
               affiliation:
                     name:Qingdao University
                     address:
                        name:Qingdao University, Qingdao, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Tao Hu
               affiliation:
                     name:Binzhou Medical University
                     address:
                        name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Side population cells derived from hUCMSCs and hPMSCs could inhibit the malignant behaviors of Tn+ colorectal cancer cells from modifying their O-glycosylation status
      description:Cosmc (C1GalT1C1) mutation could cause aberrant O-glycosylation and result in expression of Tn antigen on the surface of tumor cells (Tn+ cells), which is associated with the metastasis and prognosis of cancer progression. Mesenchymal stem cells (MSCs) could participate in immunoregulation, tissue damage repair, and tumor inhibition and be seen as an ideal candidate for tumor therapy due to their inherent capacity to migrate to tumor sites. However, their therapeutic effectiveness in different tumors is inconsistent and still controversial. Of note, emerging data reveal that side population (SP) cells have a stronger multilineage developmental potential than main population cells and can function as stem/progenitor cells. The effect of SP cells derived from MSCs on the biological behaviors and the O-glycosylation status of tumor cells remains unclear. SP cells were isolated from human umbilical cord MSCs (hUCMSCs) and human placenta MSCs (hPMSCs). Tn+ cells (LS174T-Tn+ and HT-29-Tn+ cells) and matching Tnāˆ’ cells (LS174T-Tnāˆ’ and HT-29-Tnāˆ’ cells) were isolated from human colorectal cancer cell (CRC) lines LS174T and HT-29 by immune magnetic beads. The proliferation, migration, apoptosis, Tn antigen expression, and O-glycome in Tn+ and Tnāˆ’ CRC cells before and after co-cultured with SP-MSCs were detected using real-time cell Analysis (RTCA), flow cytometry (FCM), and cellular O-glycome reporter/amplification (CORA), respectively. Cosmc protein and O-glycosyltransferase (T-synthase and C3GnT) activity in CRC cells were, respectively, assessed using western blotting and fluorescence method. Both SP cells derived from hUCMSCs and hPMSCs could inhibit proliferation and migration, promote apoptosis of CRC cells, significantly reduce Tn antigen expression on Tn+ CRC cells, generate new core 1-, 2-, and 3-derived O-glycans,Ā increase T-synthase and C3GnT activity, and elevate the levels of Cosmc and T-synthase protein. SP-hUCMSCs and SP-hPMSCs could inhibit proliferation and migration and promote apoptosis of Tn+ CRC cells via increasing O-glycosyltransferase activity to modify O-glycosylation status, which further adds a new dimension to the treatment of CRC.
      datePublished:2023-05-26T00:00:00Z
      dateModified:2023-05-26T00:00:00Z
      pageStart:1
      pageEnd:19
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s13287-023-03334-3
      keywords:
         Colorectal cancer cells
         SP-hUCMSCs
         SP-hPMSCs
          O-glycosylation
         Cosmc
         Stem Cells
         Cell Biology
         Regenerative Medicine/Tissue Engineering
         Biomedical Engineering and Bioengineering
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13287-023-03334-3/MediaObjects/13287_2023_3334_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13287-023-03334-3/MediaObjects/13287_2023_3334_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13287-023-03334-3/MediaObjects/13287_2023_3334_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13287-023-03334-3/MediaObjects/13287_2023_3334_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13287-023-03334-3/MediaObjects/13287_2023_3334_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13287-023-03334-3/MediaObjects/13287_2023_3334_Fig6_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13287-023-03334-3/MediaObjects/13287_2023_3334_Fig7_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13287-023-03334-3/MediaObjects/13287_2023_3334_Fig8_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13287-023-03334-3/MediaObjects/13287_2023_3334_Fig9_HTML.png
      isPartOf:
         name:Stem Cell Research & Therapy
         issn:
            1757-6512
         volumeNumber:14
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Wen Hu
            affiliation:
                  name:Binzhou Medical University
                  address:
                     name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ruisong Ding
            affiliation:
                  name:Binzhou Medical University
                  address:
                     name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mengyang Wang
            affiliation:
                  name:Binzhou Medical University
                  address:
                     name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Panpan Huang
            affiliation:
                  name:Binzhou Medical University
                  address:
                     name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xia Wei
            affiliation:
                  name:Binzhou Medical University
                  address:
                     name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xingyou Hu
            affiliation:
                  name:Qingdao University
                  address:
                     name:Qingdao University, Qingdao, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Tao Hu
            affiliation:
                  name:Binzhou Medical University
                  address:
                     name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Stem Cell Research & Therapy
      issn:
         1757-6512
      volumeNumber:14
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Binzhou Medical University
      address:
         name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
         type:PostalAddress
      name:Binzhou Medical University
      address:
         name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
         type:PostalAddress
      name:Binzhou Medical University
      address:
         name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
         type:PostalAddress
      name:Binzhou Medical University
      address:
         name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
         type:PostalAddress
      name:Binzhou Medical University
      address:
         name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
         type:PostalAddress
      name:Qingdao University
      address:
         name:Qingdao University, Qingdao, People’s Republic of China
         type:PostalAddress
      name:Binzhou Medical University
      address:
         name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Wen Hu
      affiliation:
            name:Binzhou Medical University
            address:
               name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Ruisong Ding
      affiliation:
            name:Binzhou Medical University
            address:
               name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Mengyang Wang
      affiliation:
            name:Binzhou Medical University
            address:
               name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Panpan Huang
      affiliation:
            name:Binzhou Medical University
            address:
               name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Xia Wei
      affiliation:
            name:Binzhou Medical University
            address:
               name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Xingyou Hu
      affiliation:
            name:Qingdao University
            address:
               name:Qingdao University, Qingdao, People’s Republic of China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Tao Hu
      affiliation:
            name:Binzhou Medical University
            address:
               name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
      name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
      name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
      name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
      name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
      name:Qingdao University, Qingdao, People’s Republic of China
      name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China

External Links {šŸ”—}(273)

Analytics and Tracking {šŸ“Š}

  • Google Tag Manager

Libraries {šŸ“š}

  • Prism.js

CDN Services {šŸ“¦}

  • Crossref

4.76s.